Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15331161rdf:typepubmed:Citationlld:pubmed
pubmed-article:15331161lifeskim:mentionsumls-concept:C0002395lld:lifeskim
pubmed-article:15331161lifeskim:mentionsumls-concept:C0017982lld:lifeskim
pubmed-article:15331161lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:15331161lifeskim:mentionsumls-concept:C0443172lld:lifeskim
pubmed-article:15331161lifeskim:mentionsumls-concept:C0449445lld:lifeskim
pubmed-article:15331161pubmed:issue2lld:pubmed
pubmed-article:15331161pubmed:dateCreated2004-8-27lld:pubmed
pubmed-article:15331161pubmed:abstractTextGlycosylation influences the biological activity of proteins and affects their folding and stability. Because aberrant glycosylation is associated with Alzheimer's disease (AD), we applied proteome analysis together with Pro-Q Emerald 300 glycoprotein staining to investigate changes in glycosylated cytosolic proteins in AD and control brain. Frontal cortex proteins from 10 AD patients and 7 non-demented controls were subjected to separation by two-dimensional gel electrophoresis and subsequently stained with carbohydrate-specific Pro-Q Emerald 300 dye. Changes in glycosylation of separated proteins were quantified, and proteins of interest identified by mass spectrometry. Approximately 30% of all detectable proteins in the human frontal cortex appeared glycosylated, including heat shock cognate 71 stress protein and beta isoform of creatine kinase. The glycosylation of collapsin response mediator protein 2 (CRMP-2) and an unknown protein was reduced in AD, while the glycosylation of glial fibrillary acidic protein was increased. CRMP-2 regulates the assembly and polymerization of microtubules and is associated with neurofibrillary tangles in AD. Aberrant glycosylations in AD may help understand the mechanisms of neurodegenerative diseases.lld:pubmed
pubmed-article:15331161pubmed:languageenglld:pubmed
pubmed-article:15331161pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15331161pubmed:citationSubsetIMlld:pubmed
pubmed-article:15331161pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15331161pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15331161pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15331161pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15331161pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15331161pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15331161pubmed:statusMEDLINElld:pubmed
pubmed-article:15331161pubmed:monthSeplld:pubmed
pubmed-article:15331161pubmed:issn0304-3940lld:pubmed
pubmed-article:15331161pubmed:authorpubmed-author:GoldsteinsGun...lld:pubmed
pubmed-article:15331161pubmed:authorpubmed-author:KoistinahoJar...lld:pubmed
pubmed-article:15331161pubmed:authorpubmed-author:AuriolaSeppoSlld:pubmed
pubmed-article:15331161pubmed:authorpubmed-author:AlafuzoffIrin...lld:pubmed
pubmed-article:15331161pubmed:authorpubmed-author:KanninenKatja...lld:pubmed
pubmed-article:15331161pubmed:issnTypePrintlld:pubmed
pubmed-article:15331161pubmed:day2lld:pubmed
pubmed-article:15331161pubmed:volume367lld:pubmed
pubmed-article:15331161pubmed:ownerNLMlld:pubmed
pubmed-article:15331161pubmed:authorsCompleteYlld:pubmed
pubmed-article:15331161pubmed:pagination235-40lld:pubmed
pubmed-article:15331161pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15331161pubmed:meshHeadingpubmed-meshheading:15331161...lld:pubmed
pubmed-article:15331161pubmed:meshHeadingpubmed-meshheading:15331161...lld:pubmed
pubmed-article:15331161pubmed:meshHeadingpubmed-meshheading:15331161...lld:pubmed
pubmed-article:15331161pubmed:meshHeadingpubmed-meshheading:15331161...lld:pubmed
pubmed-article:15331161pubmed:meshHeadingpubmed-meshheading:15331161...lld:pubmed
pubmed-article:15331161pubmed:meshHeadingpubmed-meshheading:15331161...lld:pubmed
pubmed-article:15331161pubmed:meshHeadingpubmed-meshheading:15331161...lld:pubmed
pubmed-article:15331161pubmed:meshHeadingpubmed-meshheading:15331161...lld:pubmed
pubmed-article:15331161pubmed:meshHeadingpubmed-meshheading:15331161...lld:pubmed
pubmed-article:15331161pubmed:meshHeadingpubmed-meshheading:15331161...lld:pubmed
pubmed-article:15331161pubmed:meshHeadingpubmed-meshheading:15331161...lld:pubmed
pubmed-article:15331161pubmed:meshHeadingpubmed-meshheading:15331161...lld:pubmed
pubmed-article:15331161pubmed:meshHeadingpubmed-meshheading:15331161...lld:pubmed
pubmed-article:15331161pubmed:meshHeadingpubmed-meshheading:15331161...lld:pubmed
pubmed-article:15331161pubmed:meshHeadingpubmed-meshheading:15331161...lld:pubmed
pubmed-article:15331161pubmed:meshHeadingpubmed-meshheading:15331161...lld:pubmed
pubmed-article:15331161pubmed:year2004lld:pubmed
pubmed-article:15331161pubmed:articleTitleGlycosylation changes in Alzheimer's disease as revealed by a proteomic approach.lld:pubmed
pubmed-article:15331161pubmed:affiliationDepartment of Neurobiology, A.I. Virtanen Institute for Molecular Sciences, University of Kuopio, Neulaniementie 2, P.O. Box 1627, FIN-70211 Kuopio, Finland.lld:pubmed
pubmed-article:15331161pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15331161pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:15331161pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15331161lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15331161lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15331161lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15331161lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15331161lld:pubmed